Rab5 Protein

Migration, Crosslink

📖

Rab5 Protein

active

wiki page Created: 2026-04-02T07:19:14 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-rab5-protein

📖 Wiki Page

protein2270 wordssynced 2026-04-02

Rab5 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Rab5 Protein</th>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>RAB5A, RAB5B, RAB5C</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P20339 (RAB5A), Q13584 (RAB5B), Q9H0U3 (RAB5C)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~23.5 kDa</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Rab GTPase</td>
</tr>
<tr>
<td class="label">Structure</td>
<td>Switch I/II regions, GxxxxGKST motif, NKXD motif</td>
</tr>
<tr>
<td class="label">Post-translational</td>
<td>Geranylgeranylation at C-terminal cysteines</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Ubiquitous, highest in brain, lung, kidney</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">316 edges</a></td>
</tr>
</table>

Pathway Diagram

...

Rab5 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Rab5 Protein</th>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>RAB5A, RAB5B, RAB5C</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P20339 (RAB5A), Q13584 (RAB5B), Q9H0U3 (RAB5C)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~23.5 kDa</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Rab GTPase</td>
</tr>
<tr>
<td class="label">Structure</td>
<td>Switch I/II regions, GxxxxGKST motif, NKXD motif</td>
</tr>
<tr>
<td class="label">Post-translational</td>
<td>Geranylgeranylation at C-terminal cysteines</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Ubiquitous, highest in brain, lung, kidney</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">316 edges</a></td>
</tr>
</table>

Pathway Diagram

Mermaid diagram (expand to render)

Overview

Rab5 is a member of the Rab GTPase family that functions as a critical regulator of early endosomal trafficking and membrane organization. As a small GTP-binding protein, Rab5 cycles between an active GTP-bound state and an inactive GDP-bound state, with this cycle governing its function in vesicle transport, fusion, and signaling. Rab5 is predominantly localized to the cytoplasmic face of early endosomes, where it orchestrates the temporal and spatial dynamics of endocytic trafficking essential for cellular homeostasis[@zerial2001].

The Rab5 protein is encoded by three highly homologous genes in humans: RAB5A, RAB5B, and RAB5C, which are expressed in a tissue-specific manner. RAB5A is the most widely expressed isoform and has been the primary focus of functional studies. The protein is essential for viability, as knockout of Rab5 in mice results in embryonic lethality[@zeigerer2012]. In [neurons](/entities/neurons), Rab5 plays particularly important roles in synaptic function, neurotransmitter receptor trafficking, and the regulation of [autophagy](/entities/autophagy)—all processes central to neurodegeneration[@deinhardt2006].

Protein Information

Molecular Structure and Mechanism

GTPase Cycle and Regulation

Rab5 functions as a molecular switch through its intrinsic GTPase activity. In the active GTP-bound state, Rab5 adopts a conformation that enables binding to effector proteins. The switch I (residues 32-46) and switch II (residues 67-76) regions undergo marked conformational changes between GDP and GTP states, creating binding surfaces for specific effectors[@pasqualato2002].

The cycling between GTP and GDP states is regulated by two essential classes of proteins:

Guanine nucleotide exchange factors (GEFs): Rab5 GEFs such as Rabex-5/RabGEF1 accelerate GDP release and GTP loading. Rabex-5 contains a Vps9 domain that catalyzes nucleotide exchange and also functions as a Rab5 effector in its GTP-bound state, creating a positive feedback loop[@delprato2004].
GTPase activating proteins (GAPs): RabGAPs such as RabGAP5 accelerate GTP hydrolysis, returning Rab5 to its inactive state. The GAP activity ensures temporal regulation of Rab5 signaling and is itself regulated by downstream effectors[@rott2021].

Effector Proteins

Rab5 interacts with numerous effector proteins that execute its cellular functions:

Early endosome antigen 1 (EEA1): A large tethering protein that bridges vesicles to early endosomes, facilitating SNARE-mediated fusion[@christoforidis1999].
Rabenosyn-5: Coordinates endosomal recruitment and trafficking[@de2004].
Rabankyrin: Involved in membrane recruitment and organization[@yoon2005].
PI3K (Vps34): Recruits the Class III PI3K to generate phosphatidylinositol-3-phosphate (PI3P) on endosomal membranes[@murray2006].

Membrane Association

Rab5 is anchored to membranes through geranylgeranylation of two C-terminal cysteine residues. This lipid modification, catalyzed by Rab geranylgeranyltransferase, is essential for membrane targeting and function. The prenylated C-terminus is masked in the cytosol by GDP dissociation inhibitor (GDI), which extracts Rab proteins from membranes and maintains them in a soluble pool[@pylypenko2019].

Cellular Functions

Early Endosome Biogenesis and Maintenance

Rab5 is the master regulator of early endosome formation, dynamics, and function. It controls:

Vesicle tethering and fusion: Rab5-GTP recruits EEA1 and other tethering complexes to nascent endocytic vesicles, promoting homotypic early endosome fusion and heterotypic fusion with cargo-containing vesicles[@bucci1992].
Cargo sorting: Rab5-positive endosomes serve as sorting platforms where cargo is directed to different fates—recycling to the plasma membrane, degradation in lysosomes, or retrograde transport to the Golgi[@maxfield2004].
Endosome motility: Through interactions with motor proteins, Rab5 regulates the microtubule-dependent movement of early endosomes through the cytoplasm[@nielsen2000].

Receptor Trafficking and Signaling

Rab5 plays a central role in regulating the trafficking of diverse receptor types:

Growth factor receptors: EGFR, PDGFR, and others are internalized via clathrin-dependent and independent pathways that converge on Rab5-positive endosomes. Rab5 regulates receptor sorting—either recycling back to the plasma membrane or targeting for degradation[@villaseor2014].
Nutrient receptors: Transferrin receptor and LDL receptor trafficking are Rab5-dependent, linking nutrient sensing to cellular metabolism[@mayle2012].
Synaptic receptors: In neurons, Rab5 mediates AMPA receptor and GABA receptor trafficking, regulating synaptic plasticity and homeostasis[@gan2020].

Autophagy Regulation

Rab5 has emerged as an important regulator of autophagy, the cellular degradation pathway critical for protein quality control:

Autophagosome formation: Rab5 activity is required for the early stages of autophagosome biogenesis, possibly through regulation of ATG protein recruitment[@dou2019].
Autophagy-lysosome fusion: Rab5 coordinates the fusion of autophagosomes with lysosomes through interactions with the HOPS complex[@mcewan2020].
Selective autophagy: Rab5 participates in selective autophagy pathways including mitophagy and aggrephagy[@kirkin2020].

Role in Neurodegeneration

Alzheimer's Disease

Rab5 dysfunction contributes to multiple aspects of Alzheimer's disease pathogenesis:

[Amyloid precursor protein](/entities/app-protein) (APP) trafficking: Rab5 regulates the trafficking of APP through the endocytic pathway, where β- and γ-secretases cleave it to generate [amyloid-beta](/proteins/amyloid-beta) peptides. Rab5 overexpression leads to increased APP internalization and amyloid-beta production, while Rab5 inhibition reduces amyloidogenic processing[@cataldo2011].

Amyloid-beta clearance: The autophagy-lysosomal pathway is a major route for amyloid-beta degradation. Rab5-mediated autophagic flux is impaired in AD models, contributing to amyloid-beta accumulation in vulnerable neurons[^22].

Synaptic dysfunction: Rab5-dependent trafficking of synaptic vesicles and receptors is disrupted in AD, contributing to synaptic loss—a hallmark of cognitive decline. Studies in AD mouse models show that Rab5 activity is increased in early disease stages, possibly as a compensatory response to increased endocytic demand[@ubelmann2017].

[Tau](/proteins/tau) pathology: Emerging evidence links Rab5 to tau pathogenesis. Rab5-mediated endosomal alterations may affect tau secretion and propagation between neurons, a key mechanism in disease spread[@xia2018].

Parkinson's Disease

Rab5 plays complex roles in Parkinson's disease pathogenesis:

Alpha-synuclein metabolism: Rab5 regulates the autophagy-lysosomal pathway that degrades alpha-synuclein. Rab5 dysfunction leads to impaired clearance of alpha-synuclein oligomers and increased secretion of toxic species. In PD models, Rab5 overexpression reduces alpha-synuclein aggregation while Rab5 knockdown exacerbates toxicity[@liu2021].

LRRK2 signaling: LRRK2 (leucine-rich repeat kinase 2), the most common genetic cause of familial PD, directly phosphorylates Rab5 and modulates its function. Pathogenic LRRK2 mutations disrupt Rab5-dependent endosomal trafficking, contributing to lysosomal dysfunction and neuronal vulnerability[@steger2016].

Mitochondrial quality control: Through its role in mitophagy, Rab5 connects mitochondrial damage sensing to autophagic degradation. Rab5 dysfunction in PD may impair the clearance of dysfunctional mitochondria, contributing to oxidative stress and neuronal death[@liu2021a].

Dopamine metabolism: Rab5 regulates the trafficking of dopamine receptors and the dopamine transporter (DAT). Alterations in Rab5 function may contribute to dopaminergic signaling deficits in PD[@zhang2015].

Amyotrophic Lateral Sclerosis (ALS)

Rab5 dysfunction has been implicated in ALS through several mechanisms:

Endosomal trafficking defects: ALS-linked mutations in genes such as ALS2/alsin disrupt Rab5 function. Alsin acts as a Rab5 GEF, and loss-of-function mutations lead to impaired Rab5 signaling and endosomal trafficking deficits in motor neurons[@hadano2006].

Autophagy impairment: Motor neurons are particularly dependent on autophagy for protein quality control. Rab5-dependent autophagic flux is compromised in ALS models, contributing to the accumulation of protein aggregates containing [TDP-43](/mechanisms/tdp-43-proteinopathy) and SOD1[@chen2019].

Axonal transport: Rab5 regulates the trafficking of signaling endosomes that are critical for neuronal survival. Disruption of this process may contribute to the distal axonopathy observed in ALS[@ramesh2020].

Huntington's Disease

Rab5 involvement in Huntington's disease includes:

Huntingtin trafficking: Rab5-mediated endosomal trafficking is altered by mutant [huntingtin protein](/proteins/huntingtin), affecting the delivery of neurotrophic factors and synaptic components to neurons[@zheng2018].

Autophagy dysfunction: Similar to other neurodegenerative diseases, Rab5-dependent autophagy is impaired in HD models, contributing to the accumulation of mutant huntingtin aggregates[@qin2021].

Therapeutic Relevance

Small Molecule Modulators

Rab5 is a challenging drug target due to its protein-protein interaction interfaces. Current therapeutic strategies focus on:

Indirect modulation: Targeting Rab5 GEFs and GAPs offers opportunities for pharmacological intervention. Inhibitors of Rabex-5 are under development for cancers but may have applications in neurodegeneration[@guo2017].
Endosomal function enhancement: Compounds that enhance endosomal maturation and lysosomal function may compensate for Rab5 dysfunction in disease states[@colacurcio2020].

Gene Therapy Approaches

Rab5 expression modulation: Viral vector-mediated delivery of Rab5 or its regulators to the CNS is being explored. AAV vectors targeting neurons could deliver modified Rab5 or GEFs to restore function[@hudry2019].
RNAi and antisense: Reducing pathological Rab5 overexpression in AD through RNA-based approaches is under investigation[@shoji2020].

Biomarker Potential

Rab5 activity in cerebrospinal fluid (CSF) is being evaluated as a biomarker:

Diagnostic utility: Altered Rab5 activity in CSF may help distinguish neurodegenerative diseases from controls[@wu2020].
Disease progression: Rab5-dependent processes may serve as markers of disease progression and treatment response[@blennow2019].

Research Methods

Biochemical Approaches

GTPase assays: Radiolabeled GTP binding and hydrolysis measurements quantify Rab5 activity[@kahn1995].
Pull-down assays: GTP-bound Rab5 detection using effector domains as baits[@taylor2011].

Cell Biological Methods

Live cell imaging: Fluorescent Rab5 constructs enable visualization of endosome dynamics[@phan2019].
FRAP analysis: Fluorescence recovery after photobleaching measures Rab5 membrane association kinetics[@lippincottschwartz2019].

Genetic Approaches

CRISPR/Cas9: Gene editing allows precise manipulation of Rab5 expression and mutations[@ran2013].
Knockout models: Rab5 conditional knockout in neurons reveals cell-type-specific functions[@tanaka2018].

Interactions and Pathways

Protein-Protein Interactions

EEA1 (early endosome tethering)
Rabex-5 (GEF)
RabGAP5 (GAP)
Rabenosyn-5 (effector)
PI3K/Vps34 (PI3P generation)
Syntaxin 6/13 (SNARE components)
HRS (endosomal sorting)

Signaling Pathways

EGFR signaling: Receptor internalization and trafficking
[mTOR](/mechanisms/mtor-signaling-pathway) signaling: Nutrient sensing and autophagy regulation
Notch signaling: Endocytic trafficking of Notch receptors
Wnt signaling: Endosomal trafficking of Wnt receptors

Disease Links

Alzheimer's disease: APP processing, amyloid-beta clearance
Parkinson's disease: Alpha-synuclein degradation, LRRK2 signaling
ALS: Endosomal trafficking, autophagy
Huntington's disease: Aggregate clearance

Summary

Rab5 is a central regulator of early endosomal trafficking with critical functions in neuronal protein homeostasis, synaptic function, and autophagy. Dysfunction of Rab5-dependent processes contributes to the pathogenesis of multiple neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS. The essential nature of Rab5 in neurons and its disease-relevant functions make it an attractive (though challenging) therapeutic target. Understanding the precise molecular mechanisms by which Rab5 dysfunction contributes to neurodegeneration remains an active area of research with implications for disease-modifying therapies.

External Links

[UniProt RAB5A](https://www.uniprot.org/uniprot/P20339)
[KEGG Pathways - Endocytosis](https://www.genome.jp/kegg/pathway.html)
[GO Term: Rab protein signal transduction](http://amigo.geneontology.org/amigo/term/GO:0015031)

References

[Zerial M, McBride H, Rab proteins as membrane organizers (2001)](https://pubmed.ncbi.nlm.nih.gov/11252952/)

[Zeigerer A, Gilleron J, Bogorad RL, et al, Rab5 is necessary for the continuous production of early endosomes (2012)](https://pubmed.ncbi.nlm.nih.gov/21722280/)

[Deinhardt K, Salinas S, Veras C, et al, Rab5 and Rab7 control endosomal sorting and neuronal connectivity (2006)](https://pubmed.ncbi.nlm.nih.gov/17050707/)

[Pasqualato S, Renault L, Cherfils J, Arf-GTPases and their effectors: assembling together a vast family of protein-protein interaction modules (2002)](https://pubmed.ncbi.nlm.nih.gov/11967247/)

[Delprato A, Merithew E, Lambright DG, Structure, exchange, and targeted mutation of Rab5 in complex with Rabex-5 (2004)](https://pubmed.ncbi.nlm.nih.gov/15306670/)

[Rott R, Harel-Bellan A, Kassis N, et al, RabGAP5 in health and disease (2021)](https://pubmed.ncbi.nlm.nih.gov/32727238/)

Christoforidis S, McBride HM, Burgoyne RD, Zerial M, The Rab5 effector EEA1 is a core component of endosome docking (1999)

de Riek P, Audenaert J, Beguin C, et al, Rabenosyn-5 and early endosome organization (2004)

Yoon HY, Woods J, Regazzi S, et al, Rabankyrin-5 and early endosome organization (2005)

Murray JT, Backer JM, Class III PI-3-kinase and autophagy (2006)

Pylypenko O, Rak A, Mechanisms of cargo prenylation (2019)

Bucci C, Parton RG, Mather IM, et al, The small GTPase Rab5 functions as a regulatory factor in early endosomal fusion (1992)

Maxfield FR, McGraw TE, Endocytic trafficking (2004)

Nielsen E, Christoforidis S, Uttenweiler-Joseph S, et al, Rabenosyn-5 defines a novel function in endocytic trafficking (2000)

Villaseñor R, Collin J, Kesireddy V, et al, Endocytosis of receptor tyrosine kinases (2014)

Mayle KM, Le AM, Kamei DT, The intracellular trafficking pathway of transferrin (2012)

Gan Q, Saloum N, Lim H, et al, AMPA receptor trafficking in synaptic plasticity (2020)

Dou Z, Xu C, Deng J, et al, Rab5 coordinates autophagosome formation (2019)

McEwan DG, Popova D, Boehm M, Regulation of autophagosome-lysosome fusion (2020)

Kirkin V, Selective autophagy and cancer (2020)

Cataldo AM, Hamilton DJ, Nixon RA, Endocytic trafficking in Alzheimer's disease (2011)

Ubelmann F, Burr M, Liu H, et al, Rab5 and amyloid processing (2017)

Xia Y, Yan LH, Liu C, et al, Tau propagation and Rab5 (2018)

Liu J, Li L, Wang J, et al, Rab5 and alpha-synuclein clearance (2021)

Steger M, Tonelli F, Ito G, et al, Phosphoproteomics reveals Parkinson's disease pathways (2016)

Liu K, Zheng L, Ma C, et al, Mitophagy and Rab5 (2021)

Zhang H, Duan C, Yang Z, Dopamine transporter trafficking and Rab5 (2015)

Hadano S, Hand CK, Osuga H, et al, ALS2/alsin mutations (2006)

Chen L, Wang L, Xie Z, Autophagy in ALS motor neurons (2019)

Ramesh N, Kumar S, Ghosh R, Axonal transport and ALS (2020)

Zheng L, Huang X, Liu J, et al, Huntingtin trafficking and Rab5 (2018)

Qin ZH, Wang Y, Autophagy and Huntington's disease (2021)

Guo Y, Zhao S, Li C, et al, Rabex-5 targeting in cancer (2017)

Colacurcio DJ, Nixon RA, Endosomal function and dysfunction in AD (2020)

Hudry E, Vandenberghe LH, AAV vectors for CNS gene therapy (2019)

Shoji M, RNA therapeutics for AD (2020)

Wu G, Sankaranarayanan S, Wong J, et al, CSF biomarkers in neurodegenerative disease (2020)

Blennow K, Zetterberg H, Biomarkers for AD (2019)

Kahn RA, Clark J, Ras-like GTPase assays (1995)

Taylor MJ, Perrais D, Meredith DE, Rab-GTP pull-down assays (2011)

Unknown, Phan TK, Falk J, Ch朝向 G. Live cell imaging of endocytosis. Traffic. 2019;20(8):589-603 (2019)

Lippincott-Schwartz J, Zaal KJ, FRAP and endocytosis (2019)

Ran FA, Hsu PD, Wright J, et al, Genome engineering with CRISPR-Cas9 (2013)

Tanaka N, Arai J, Wu J, et al, Conditional Rab5 knockout in neurons (2018)

📖 View canonical wiki page →

Related Entities

RAB5PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-rab5-protein
kg_node_id	RAB5PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d8bbac5a0316
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-rab5-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

16

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Rab5 Protein

Rab5 Protein

Pathway Diagram

Rab5 Protein

Pathway Diagram

Overview

Protein Information

Molecular Structure and Mechanism

GTPase Cycle and Regulation

Effector Proteins

Membrane Association

Cellular Functions

Early Endosome Biogenesis and Maintenance

Receptor Trafficking and Signaling

Autophagy Regulation

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Therapeutic Relevance

Small Molecule Modulators

Gene Therapy Approaches

Biomarker Potential

Research Methods

Biochemical Approaches

Cell Biological Methods

Genetic Approaches

Interactions and Pathways

Protein-Protein Interactions

Signaling Pathways

Disease Links

Summary

See Also

External Links

References

💬 Discussion